Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| AMAROQ | - | 5 | +2,86 % | ||
 | FESTI | - | 4 | - | |
| HEIMAR | - | 3 | - | |
| JBT MAREL | - | 2 | -2,61 % | ||
| ARION BANK | - | 1 | -1,73 % | ||
| EIMSKIP | - | 1 | - | |
| ICELANDAIR GROUP HF | - | - | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - | |
| SJOVA | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Nasdaq announces semi-annual changes to the OMX Iceland 15 Index: Síldarvinnslan hf. will be added and Skagi hf. will be removed from the Index | 166 | GlobeNewswire | Reykjavik, November 21, 2025 - Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Iceland 15 Index, (Nasdaq Iceland: OMXI15), which will become effective at market... ► Artikel lesen | |
| Fr | Alvotech and Advanz announce EC approval for Gobivaz biosimilar | 5 | Pharmaceutical Business Review | ||
| Fr | Alvotech and Advanz announce EC approval for Gobivaz biosimilar | 4 | Pharmaceutical Technology | ||
| Do | Festi hf.: Major shareholder announcement from Lífeyrissjóður verzlunarmanna | 3 | GlobeNewswire (USA) | ||
| Do | Alvotech - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Do | Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar | 3 | Seeking Alpha | ||
| Do | European Commission approves Alvotech's biosimilar golimumab | 7 | Investing.com | ||
| Do | Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) | 3 | GlobeNewswire (USA) | ||
| Do | Alvotech S.A.: Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) | 851 | GlobeNewswire (Europe) | Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ("Advanz Pharma"), a... ► Artikel lesen | |
| Mi | Amaroq Ltd: Amaroq extends debt financing with Landsbankinn | 2 | Stockwatch | ||
| Mi | Amaroq improves terms of its debt financing package | 4 | Alliance News | ||
| Mi | Amaroq secures improved debt financing terms with Landsbankinn | 4 | Sharecast | ||
| Mi | Amaroq Ltd.: Improved debt financing agreement | 108 | GlobeNewswire (Europe) | Reykjavík, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd.("Amaroq" or the "Company") Improved debt financing agreement TORONTO, ONTARIO - 19 November 2025 - Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland:... ► Artikel lesen | |
| Di | Oculis Holding AG: Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities | 3 | GlobeNewswire (USA) | ||
| Di | Íslandsbanki hf.: Moody's Ratings affirms Íslandsbanki's A3 long-term issuer ratings with a stable outlook | 71 | GlobeNewswire (Europe) | Moody's Ratings (Moody's) has today affirmed Íslandsbanki's A3 long-term foreign and local currency issuer ratings, the A2 long-term and P-1 short-term foreign and local currency deposit ratings, and... ► Artikel lesen | |
| Mo | Eimskipafelag Islands hf.: Transaction in relation to a share buy-back program | 2 | GlobeNewswire (USA) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .